A Trial-Length A/B Test With a Counterintuitive Result

A SaaS client ran a 14-day free trial and wanted to test whether shortening it to 7 days would increase urgency and lift conversion — a reasonable hypothesis backed by plenty of conventional wisdom about scarcity driving action. We tested 7-day against a lengthened 21-day trial as the two variants. The 21-day trial won, converting at a rate about 23% higher than the 7-day version.

Why longer won for this specific product

The product had a real activation bottleneck: it typically took a new user 9-12 days to get through an onboarding integration process before they could see the core value at all. A 7-day trial expired before most users had even gotten there, so they were being asked to convert based on almost no real usage. The 21-day trial gave enough runway for most users to actually reach the value moment before the decision point arrived.

Urgency only helps conversion if the user has already gotten enough value to feel urgency about keeping it. Otherwise it's just cutting the trial short before the product had a chance to work.

What this means beyond this one test

• Trial length should be set relative to the product's actual time-to-value, not a generic industry default.
• A shorter trial can work well for products with fast activation — this result doesn't generalize as "longer trials always win."
• Measuring time-to-value directly, before running the trial-length test, would have predicted this result without needing the test at all.
• Any trial-length test should segment results by whether the user actually reached activation within the trial window, not just look at the blended conversion rate.

The counterintuitive result stopped being counterintuitive the moment we looked at the activation timeline instead of trusting the general urgency-wins heuristic. The test was worth running, but the diagnostic work that explained the result was worth more than the test itself.